BSECompany Update9 Oct 2026 · 9 Oct 2026, 04:16 pm
Attached
Dr. Lal PathLabs Ltd · 539524
✦ AI Summary
Dr. Lal PathLabs Ltd has submitted a certificate confirming compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dr. Lal PathLabs Ltd - 539524 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Attachments (1)
📄pdf
Download →
cefdcbca-6691-4d56-ba45-ce40379f2862.pdf
View document text
October 09, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, Corporate Relationship Department
Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers
Bandra Kurla Complex, Bandra (E) Dalal Street
Mumbai – 400051 Mumbai- 400001
Symbol: LALPATHLAB Scrip Code: 539524
Sub: Compliance under Regulation 74(5) of SEBI (Depositories and Participants)
Regulations, 2018
Dear Sir/ Madam,
Please find enclosed herewith a copy of the Certificate received from MUFG Intime India
Private Limited, Registrar & Share Transfer Agent (RTA) of the Company, confirming the
compliance under Regulation 74(5) of the SEBI (Depositories and Participants)
Regulations, 2018, for the quarter ended September 30, 2026.
This above is for your information and record.
Thanking You,
Yours Faithfully,
For Dr. Lal PathLabs Limited
Vinay Gujral
Company Secretary & Compliance Officer
Encl.: As Above
Classification: Confidential